III PV TRAINING: Leading experts make success possible
PVpharm led the way in pharmacovigilance training by innovatively organizing another edition of its Pharmacovigilance Training. This 3rd edition was hosted on May, 2022.
Information about PVpharm
Time to meet in person again: PV TRAINING III EDITION
PVpharm organizes its successful Pharmacovigilance Training. This 3rd edition will be hosted in Madrid on May 30 and 31, 2022, with the option of attending online.
International Women’s Day at PVpharm
PVpharm is made up of women who battle every day to show the world their strength and worth. Today more than ever, we have in mind all those girls and women who still do not have access to opportunities
PVpharm becomes member of ASEBIO
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
Christmas 2021: the most unique moments
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
Christmas 2021 arrives at PVpharm
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
PVpharm invited to ICARO Awards 2021 from University of AlmerÃa
PVpharm has been invited to the ICARO Awards from the University of AlmerÃa (UAL) one more year. This act recognises the importance of the alliance between PVpharm and the highest educational institution in AlmerÃa, the University.
New Clinical Trials Information System (CTIS): key areas
The European Commission has informed that the entry into application of the Clinical Trials Regulation (CTR) and hence the go-live date for the CTIS will be on 31 January 2022.
PVpharm’s offsite meeting 2021: a memorable event (VIDEO)
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
PVpharm contributes to a recent article about the Covid vaccine
"Pharmacovigilance in times of COVID-19 vaccines", is an article published in the Spanish journal Pharmatech and in which José Alberto Ayala Ortiz has been co-author. The world is facing the unprecedented challenge of the SARS-CoV-2 pandemic. The hope for a normal life relied on vaccines is compromised by messages that question them. For this reason, pharmacovigilance activities carried out by authorities, pharmaceutical laboratories, health professionals and patients are essential to assess information and not to rely on "fake news". In this regard, the article aims to highlight the role of pharmacovigilance. It is important that society, in addition to being…